Viatris faces US FDA regulatory action on its Indore, India facility, with a warning letter and import alert restricting 11 ...

US pharma major Bristol Myers Squibb has announced positive results from POETYK PsA-1 (IM011-054) and POETYK PsA-2 (IM011-055 ...

AstraZeneca and Daiichi Sankyo withdraw EU application for datopotamab deruxtecan in NSCLC after Phase III trial shows no ...

The US Food and Drug Administration (FDA) revealed on Monday that it has approved the first generic referencing Victoza ...

The US subsidiary of Japan’s Sumitomo Pharma announced that the US Food and Drug Administration (FDA) has approved Gemtesa ...

USA-based immunology company RAPT Therapeutics has entered into an exclusive license agreement with Shanghai Jemincare ...

USA-based clinical-stage biopharma Traws Pharma saw its shares leap more than 150% to $12.57 as it announced progress in the ...

The US Food and Drug Administration (FDA) on Friday approved an expanded indication for Imcivree (setmelanotide), from Boston ...

French pharma major Sanofi says it has entered into a new chapter of the collaboration with South Korean firm SK bioscience ...

Shionogi to acquire full ownership of its joint ventures with Ping An subsidiaries, dissolving partnerships to refocus on ...

Denmark’s Novo Nordisk today announced headline results from REDEFINE 1, a Phase III trial in the global REDEFINE program, ...

Spanish plasma-based medicines maker Grifols has announced disappointing top-line data from its Phase III PRECIOSA clinical ...